(Q26775003)

English

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

systematic review

1 reference

based on heuristic

inferred from title

0 references

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

object named as

Rafael Perera

1

1 reference

ORCID Public Data File 2021

Osamu Takahashi

11

object named as

Osamu Takahashi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Teresa Pérez

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Thomas Fanshawe

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Andrew Dalton

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Andrew Farmer

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

John Stevens

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Les Irwig

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sarah Stevens

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Asuka Leslie

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Gautam Deshpande

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Kevin Urayama

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Brian Shine

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Richard Stevens

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Paul Glasziou

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

1 December 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Health Technology Assessment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1-401, vii-viii

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating an individual's true cholesterol level and response to intervention.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma cholesterol concentration and mortality. The Whitehall Study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Major lipids, apolipoproteins, and risk of vascular disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid-related markers and cardiovascular disease prediction

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins for the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid lowering efficacy of atorvastatin

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based Medical Monitoring

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Thinking

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol and serum albumin as risk factors for death in patients undergoing general surgery

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

What do we mean by validating a prognostic model?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple imputation for an incomplete covariate that is a ratio

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum lipids and their association with mortality in the elderly: a prospective cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum total cholesterol and mortality in a Japanese population

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of statin-induced muscle problems in clinical trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and laboratory predictors of all-cause mortality in older population.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Less than 50% of variation in HDL cholesterol between and within individuals, is explained by established predictors

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Menopause, age, and cardiovascular risk: a complex relationship

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

EMBASE search strategies achieved high sensitivity and specificity for retrieving methodologically sound systematic reviews.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

In a population-based cohort of diabetes patients, men and women had similar risks for all-cause mortality.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Monthly intra-individual variation in lipids over a 1-year period in 22 normal subjects

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparisons of medical tests: sometimes invalid, not always efficient

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Fire-and-forget in prevention of coronary heart disease.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

OTC statins: a bad decision for public health

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The UK General Practice Research Database

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure re-screening for healthy adults: what is the best measure and interval?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol is a risk factor for myocardial infarction in elderly men and women: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality rates and risk factors for coronary disease in black as compared with white men and women

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose atorvastatin after stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma fibrinogen and coronary heart disease in urban Japanese

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective reporting biases in cancer prognostic factor studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elderly Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeat measurement of case-control data: correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density lipoprotein cholesterol reduction by inhibition of PCSK9.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid assessment, metabolic syndrome and coronary heart disease risk

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of mortality in the prospective Dubbo study of Australian elderly

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Low high-density lipoprotein 3 reduces the odds of men surviving to age 85 during 53-year follow-up

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategy of prevention: lessons from cardiovascular disease.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Total cholesterol concentration and mortality at a relatively young age: do men and women differ?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring in chronic disease: a rational approach

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal search strategies for retrieving systematic reviews from Medline: analytical survey

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: systematic review

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin prescriptions in UK now total a million each week

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-cardiovascular effects associated with statins

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the rates of weight and waist circumference gain in Australian adults over time: a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated ApoB serum levels strongly predict early cardiovascular events

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid re-screening: what is the best measure and interval?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative total mortality in 25 years in Italian and Greek middle aged rural men

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombogenic factors and recurrent coronary events

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of statins on skeletal muscle function

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemostatic factors as predictors of coronary events and total mortality: The FINRISK '92 Hemostasis Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension awareness and psychological distress.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical models for the control phase of clinical monitoring

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The Prediction of Coronary Heart Disease Mortality as a Function of Major Risk Factors in Over 30000 Men in the Italian RIFLE Pooling Project. A Comparison with the MRFIT Primary Screenees

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of cardiovascular events in patients at optimal values for combined lipid parameters

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

All-cause mortality and risk factors in a cohort of retired military male veterans, Xi'an, China: an 18-year follow up study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of prognostic models in traumatic brain injury

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study o

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression dilution in the proportional hazards model.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the parameters in the Cox model when covariate variables are measured with error.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD)

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review and economic evaluation of statins for the prevention of coronary events.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

The rise of cholesterol testing: how much is unnecessary

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between coronary artery disease and non-HDL-C, and effect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol and coronary heart disease: predicting risks by levels and ratios

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Translating clinical research into clinical practice: impact of using prediction rules to make decisions

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the quality of prognosis studies in systematic reviews

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring cholesterol levels: measurement error or true change?

1 reference

https://api.crossref.org/works/10.3310%2FHTA191000

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.3310/HTA191000

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26680162%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26775003&oldid=2098465399"